BIG PHARMA'S BIG SELL TO DOCTORS

A A

Sarah Boseley has helpfully drawn our attention to the report about breaches to the ethical marketing codes of the pharmaceutical industry. We have spoken out about many of these issues, having recognised the influence that marketing may have on medical practice. We have succeeded in reducing the drug company "sponsorship" of our work to less than 5%, and have clear guidelines addressing both corporate and individual relationships with the industry. The Guardian (http://society.guardian.co.uk/health/comment/0,,1809669,00.html)